JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, J. W.
Right arrow Articles by Barbas, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, J. W.
Right arrow Articles by Barbas, C. F., 3rd
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 269, Issue 52, 32788-32795, Dec, 1994

Building synthetic antibodies as adhesive ligands for integrins

JW Smith, D Hu, A Satterthwait, S Pinz-Sweeney and CF Barbas 3rd
Department of Vascular Biology, Scripps Research Institute, La Jolla, California 92037.

An antibody engineering strategy was employed to build high affinity ligands and antagonists of integrins alpha v beta 3 and alpha IIb beta 3. Previously, we inserted the integrin recognition motif, RGD, into the antigen binding site of a human antibody and selected the optimal flanking sequences from a phage-display library (Barbas, C. F., Languino, L. R., and Smith, J. W. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 10003-10007). The resulting antibody, Fab-9, blocked the function of integrin alpha v beta 3 but also bound to the ligand binding site of platelet integrin alpha IIb beta 3. In this report, the antibody engineering effort has been extended by 1) redesigning Fab-9 to achieve specificity for platelet integrin alpha IIb beta 3, 2) building non-RGD- containing antibodies that bind the ligand binding site of both beta 3- integrins, and 3) testing the hypothesis that peptides derived from complementarity determining regions (CDR) can be used to emulate the activity of the parent synthetic antibody. These goals were accomplished by subjecting the original antibody, Fab-9, to a "motif optimization" (MTF). A phage library was constructed in which the residues flanking the RGD motif in Fab-9 were maintained, but the RGDX sequence was randomized. This library was panned on purified alpha IIb beta 3 to identify high affinity binders. Four function-blocking antibodies lacking RGD, but with specificity for alpha IIb beta 3, were characterized. The antibody with the highest preference for alpha IIb beta 3, MTF-10, had an adhesion sequence of KGDN. This sequence is similar in primary structure to the active sequence within the disintegrin barbourin, which also antagonizes alpha IIb beta 3 (Scarborough, R. M., Rose, J. W., Hsu, M. A., Phillips, D. R., Fried, V. A., Campbell, A. M., Nannizzi, L., and Charo, I. F. (1991) J. Biol. Chem. 266, 9359-9362). MTF-10 had a 70-fold higher affinity for alpha IIb beta 3 than alpha v beta 3. Through our selection strategy, we also identified several antibodies that lack RGD but still blocked ligand binding to both integrins with high affinity. Therefore, the RGD sequence is not necessary for a high affinity interaction with the ligand binding site of beta 3-integrins. Further investigation showed that the activity of inhibitory antibodies could be emulated by synthetic peptides derived from the protein sequences of the antibody's HCDR3. CDR-derived peptides blocked ligand binding to integrins and maintained essentially the same specificity as the parent antibody.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Zhuang, L. Kelo, J. B. Nardi, and M. R. Kanost
An Integrin-Tetraspanin Interaction Required for Cellular Innate Immune Responses of an Insect, Manduca sexta
J. Biol. Chem., August 3, 2007; 282(31): 22563 - 22572.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
C. J. Heap, Y. Wang, T. J. T. Pinheiro, S. A. Reading, K. R. Jennings, and N. J. Dimmock
Analysis of a 17-amino acid residue, virus-neutralizing microantibody
J. Gen. Virol., June 1, 2005; 86(6): 1791 - 1800.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. H. Weinreb, K. J. Simon, P. Rayhorn, W. J. Yang, D. R. Leone, B. M. Dolinski, B. R. Pearse, Y. Yokota, H. Kawakatsu, A. Atakilit, et al.
Function-blocking Integrin {alpha}v{beta}6 Monoclonal Antibodies: DISTINCT LIGAND-MIMETIC AND NONLIGAND-MIMETIC CLASSES
J. Biol. Chem., April 23, 2004; 279(17): 17875 - 17887.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. I. Deryugina, B. I. Ratnikov, T. I. Postnova, D. V. Rozanov, and A. Y. Strongin
Processing of Integrin alpha v Subunit by Membrane Type 1 Matrix Metalloproteinase Stimulates Migration of Breast Carcinoma Cells on Vitronectin and Enhances Tyrosine Phosphorylation of Focal Adhesion Kinase
J. Biol. Chem., March 15, 2002; 277(12): 9749 - 9756.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. W. Smith, H. Le Calvez, L. Parra-Gessert, N. E. Preece, X. Jia, and N. Assa-Munt
Selection and Structure of Ion-selective Ligands for Platelet Integrin alpha IIbbeta 3
J. Biol. Chem., March 15, 2002; 277(12): 10298 - 10305.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-J. Jacobin, J. Laroche-Traineau, M. Little, A. Keller, K. Peter, M. Welschof, A. Nurden, and G. Clofent-Sanchez
Human IgG Monoclonal Anti-{alpha}IIb{beta}3-Binding Fragments Derived from Immunized Donors Using Phage Display
J. Immunol., February 15, 2002; 168(4): 2035 - 2045.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Yan, D. D. Hu, S. K. Knowles, and J. W. Smith
Probing Chemical and Conformational Differences in the Resting and Active Conformers of Platelet Integrin alpha IIbbeta 3
J. Biol. Chem., March 15, 2000; 275(10): 7249 - 7260.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Vallar, C. Melchior, S. Plancon, H. Drobecq, G. Lippens, V. Regnault, and N. Kieffer
Divalent Cations Differentially Regulate Integrin alpha IIb Cytoplasmic Tail Binding to beta 3 and to Calcium- and Integrin-binding Protein
J. Biol. Chem., June 11, 1999; 274(24): 17257 - 17266.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. D. Hu, C. A. White, S. Panzer-Knodle, J. D. Page, N. Nicholson, and J. W. Smith
A New Model of Dual Interacting Ligand Binding Sites on Integrin alpha IIbbeta 3
J. Biol. Chem., February 19, 1999; 274(8): 4633 - 4639.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Monnet, D. Laune, J. Laroche-Traineau, M. Biard-Piechaczyk, L. Briant, C. Bes, M. Pugniere, J.-C. Mani, B. Pau, M. Cerutti, et al.
Synthetic Peptides Derived from the Variable Regions of an Anti-CD4 Monoclonal Antibody Bind to CD4 and Inhibit HIV-1 Promoter Activation in Virus-infected Cells
J. Biol. Chem., February 5, 1999; 274(6): 3789 - 3796.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. C. K. Lin, B. I. Ratnikov, P. M. Tsai, C. P. Carron, D. M. Myers, C. F. Barbas III, and J. W. Smith
Identification of a Region in the Integrin beta 3 Subunit That Confers Ligand Binding Specificity
J. Biol. Chem., September 19, 1997; 272(38): 23912 - 23920.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. C. K. Lin, B. I. Ratnikov, P. M. Tsai, E. R. Gonzalez, S. McDonald, A. J. Pelletier, and J. W. Smith
Evidence That the Integrin beta 3 and beta 5 Subunits Contain a Metal Ion-dependent Adhesion Site-like Motif but Lack an I Domain
J. Biol. Chem., May 30, 1997; 272(22): 14236 - 14243.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. J. Kunicki, D. S. Annis, and B. Felding-Habermann
Molecular Determinants of Arg-Gly-Asp Ligand Specificity for beta 3 Integrins
J. Biol. Chem., February 14, 1997; 272(7): 4103 - 4107.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. D. Hu, C. F. Barbas III, and J. W. Smith
An Allosteric Ca2+ Binding Site on the beta3-Integrins That Regulates the Dissociation Rate for RGD Ligands
J. Biol. Chem., September 6, 1996; 271(36): 21745 - 21751.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. I. Ratnikov, D. V. Rozanov, T. I. Postnova, P. G. Baciu, H. Zhang, R. G. DiScipio, G. G. Chestukhina, J. W. Smith, E. I. Deryugina, and A. Y. Strongin
An Alternative Processing of Integrin alpha v Subunit in Tumor Cells by Membrane Type-1 Matrix Metalloproteinase
J. Biol. Chem., February 22, 2002; 277(9): 7377 - 7385.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1994 by the American Society for Biochemistry and Molecular Biology.